...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and biological evaluation of 4-(3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl)-1- yl-benzonitrile as novel farnesyltransferase inhibitor.
【24h】

Synthesis and biological evaluation of 4-(3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl)-1- yl-benzonitrile as novel farnesyltransferase inhibitor.

机译:新型4-(3-联苯基-2-基-1-羟基-1-(3-甲基-3H-咪唑-4-基)-丙-2-炔基)-1-基-苄腈的合成及生物学评价法尼基转移酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Farnesyltransferase inhibitors (FTIs) have emerged as a novel class of anti-cancer agents. Analogues of the potent FTI, 4-[3-biphenyl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-be nzonitrile, were synthesized and tested in vitro for their inhibitory activities. The synthesis and detailed biological data of this series of analogues are presented.
机译:法尼基转移酶抑制剂(FTI)已作为一类新型的抗癌药出现。合成了有效的FTI类似物4- [3-联苯-1-羟基-1-(3-甲基-3H-咪唑-4-基)-丙-2-炔基] -1-基-苄腈,并在体外测试其抑制活性。介绍了该系列类似物的合成和详细的生物学数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号